Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
about
Comparative testing and pharmacovigilance of biosimilars.Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) ProjectLack of Evidence for Molecular Mimicry in HIV-Infected Subjects.Erythropoietin-induced, antibody-mediated pure red cell aplasia.Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagents.Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagents.
P2860
Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Development and evaluation of ...... etin antibodies in human sera.
@en
Development and evaluation of ...... etin antibodies in human sera.
@nl
type
label
Development and evaluation of ...... etin antibodies in human sera.
@en
Development and evaluation of ...... etin antibodies in human sera.
@nl
prefLabel
Development and evaluation of ...... etin antibodies in human sera.
@en
Development and evaluation of ...... etin antibodies in human sera.
@nl
P2093
P1476
Development and evaluation of ...... etin antibodies in human sera.
@en
P2093
Bischoff S
Gromnica-Ihle E
Haselbeck A
P304
P356
10.1016/J.JIM.2004.08.017
P577
2004-10-04T00:00:00Z